Market Overview

Celsion Halted Wednesday, Says Will Host Conference Call Jan 31


Shares of Celsion (NASDAQ: CLSN) were halted in after-hours trading on Wednesday. The company said it would hold a conference call Thursday morning at 8 am to discuss the top-line results from its Phase III HEAT Study with ThermoDox.

The HEAT Study had received a Fast Track designation from the FDA and Orphan Drug status.

Posted-In: News FDA


Related Articles (CLSN)

View Comments and Join the Discussion!

Partner Center